The latter is based upon the idea that extracellular hsp70, released by virus infection, can cross-present tumor-specific antigen to induce an effective antitumor immune response, or provide an adjuvant effect by simply activating innate immune responses [95]. Here, HSPA1A is linked to viral infectious disease.